Status:
RECRUITING
Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Conditions:
Multiple Sclerosis, MS
Neuromyelitis Optica Spectrum Disorders
Eligibility:
All Genders
18-65 years
Brief Summary
The goal of this observational study is to learn about pathogenesis and clinical prognosis of CNS IIDD in the Chinese population and to provide evidence-based clues for clinical treatment decisions. ...
Eligibility Criteria
Inclusion
- Patients aged 18-65 years with central nervous system idiopathic inflammatory demyelinating diseases (CNS IIDD);
- The clinical syndrome of the attack meets one of the following: MS, NMOSD, MOGAD, ADEM, clinically isolated syndrome, demyelinating encephalopathy, demyelinating myelitis, or brainstem encephalitis (see below A-E);
- Agree to participate in this study and sign the informed consent form.
Exclusion
- History of tumors or diagnosis of central nervous system tumors;
- Infectious lesions of the central nervous system;
- Hereditary, metabolic, toxic, vascular, or traumatic demyelinating diseases of the brain/spinal cord;
- Non-compliance with treatment and follow-up.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2035
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT06541626
Start Date
January 1 2024
End Date
December 31 2035
Last Update
August 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-sen Memorial Hospital
Guangzhou, Guangdong, China, 510120